ISSN 1980-5764 printed version

INSTRUCTIONS TO AUTHORS

 

Scope and Policy

Dementia & Neuropsychologia follows the guidelines of the ICMJE (International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals editors, updated in December 2014; available at  www.icmje.org)

In concert with the International Committee of Medical Journal Editors (ICMJE), Dementia & Neuropsychologia requires, as a precondition to be considered for publication, registration of clinical trials in a public trials registry. Acceptable trial registries include http://clinicaltrials.gov, http://isrctn.org, http://actr.org.au, http://trialregister.nl, and http://www.umin.ac.jp/ctr. For this purpose, the ICMJE defines a clinical trial as any study that prospectively assigns human subjects to intervention or comparison groups to evaluate the cause-and-effect relationships between a medical intervention and a health outcome. The trial registry name, its URL and the registration number should be included at the end of the abstract. Trials must be registered at or before commencement of patient enrollment.

In agreement with BIREME/PAHO/WHO recommendations for reporting randomized trials, authors are advised to adhere to the guidelines in the CONSORT STATEMENT (www.consort-statement.org). 

Authorship responsibility, criteria, and contributions; financial disclosure; and copyright transfer. The cover letter must include: (1) statement on authorship responsibility; (2) the contributions of each author to the manuscript, as explained in Definition of Author’s Contribution; (3) statement on financial disclosure; and (4) copyright transfer agreement. Each of these first 4 declarations must be read and signed by all authors (See Authorship Form and model of cover letter at demneuropsy.org.br).

Conflict of interest. A conflict of interest may exist when an author (or the author's institution or employer) has financial or personal relationships that could inappropriately influence (or bias) the author's decisions, work, or manuscript. Authors are expected to provide detailed information about any relevant financial interests or financial conflicts within the past 5 years and for the foreseeable future, particularly those present at the time the research was conducted and up to the time of publication. In addition, authors who have no relevant financial interests are asked to provide a statement indicating that they have no financial interests related to the material in the manuscript.

Authors are required to report detailed information regarding all financial and material support for the research and work, including but not limited to grant support, funding sources, and provision of equipment and supplies.

The policy requesting disclosure of conflicts of interest applies to all manuscript submissions, including letters to the editor and book reviews.

Definition of Author’s Contribution
To be included as an author it is expected that the person has made a significant intellectual contribution to the manuscript submitted to Dementia & Neuropsychologia. This contribution may have been in one or more of the items below:
Design of the study
Analysis of the data
Intellectual contribution to the writing of the manuscript

Funding/support and role of sponsor. All financial and material support for the research and work should be clearly and fully identified in the acknowledgment.

Data access and responsibility. For clinical trials sponsored by pharmaceutical companies, authors must state in their letter of submission that: (1) they have had full access to all the data; (2) they had the right to publish all the data; and (3) they have had the right to obtain independent statistical analyses of the data. Manuscripts containing statistical evaluations should include the name and affiliation of the statistical reviewer.

Duplicate previous publication or submission. Manuscripts are received on the understanding that they are not under simultaneous consideration by another journal or title. This information must be included in the cover letter.

Informed consent. For experimental investigations involving human or animal subjects, state in the "Methods" section of the manuscript that an appropriate institutional review board has approved the project. A copy of the approval by the Ethics Committee should be mailed with the manuscript. For those investigators who do not have access to a formal ethics review committee (institutional or regional), the principles outlined in the Declaration of Helsinki should be followed. For investigations of human subjects, state in the "Methods" section the manner in which informed consent was obtained from the subjects. A letter of consent must accompany all photographs of patients in which a possibility of identification exists. It is not sufficient to cover the eyes to mask identity. Refer to patients by number (or in anecdotal reports, by assigning fictitious names). Real names or initials should not be used in the text, tables, or illustrations.

 

Form and preparation of manuscripts

Cover letter. Designate the corresponding author, authorship responsibility, contributions of each author, financial support and conflict of interests. In addition, provide full address, e-mail, telephone, and fax numbers of the corresponding author and e-mails of other authors . The letter should also contain suggested names of three possible reviewers.

Title page. Include manuscript title and authors' names. The title should be concise and descriptive, carrying essential information on the manuscript content. The name of the authors should include the first name. At the bottom of the title page indicate: the name of the department and institution, city and country in which the study was conducted; the academic title of each author and their institutional affiliation; grant support; acknowledgements; name and address (postal and electronic) for mail.

Abstract. The abstract of original manuscripts or short communications should be structured and contain the following items: background, objective(s), methods, results and conclusions. Abstracts may contain up to 250 words. Abstracts of case reports, history notes or reviews may be unstructured and contain up to 150 words.

Key words. Include 4-6 key words or short phrases after the abstract, according to the Descriptors for Health Sciences (http://decs.bvs.br/).

Portuguese Version. Title, abstract and key words must also be provided in Portuguese (for those who do not write in Portuguese, the editorial office will translate these items).

Text. Original manuscripts may have up to 3,000 words and contain only four sections: introduction (which usually finishes by defining the objectives); methods (material and/or subjects; statistical methods; bioethical approach with the name of the Ethics Committee that approved the study and patient Informed Consent); results; discussion (which should include the limitations of the study and conclusions); and acknowledgements. Data presented in tables and illustrations should not be repeated in the text. Observations: Short communication, history note and case report: up to 1,500 words of text; reviews up to 5,000 words.”Neuroimaging through clinical cases” up to 750 words.

References. Up to 50 references may be included for original manuscripts, numbered consecutively in the order they are cited. For case reports, history note or short communications, up to 30, for “Neuroimaging through clinical cases” up to 10 and for reviews up to 150 references are allowed. The references should follow the Vancouver system and be abbreviated according to the Index Medicus or Pubmedstandard. List all authors when there are six or fewer; whereas when there are seven or more, list the first three then follow with "et al."

  • Articles: Author(s). Title. Journal year; volume: page numbers (initial-final).
  • Books: Author(s) or editor(s). Title. Edition - if not the first. City where published: publisher; year: number of pages
  • Chapter of a book: Author(s). Title. In: Book editor(s) followed by (eds), Title, Edition- if not the first. City where published: publisher; year:page numbers (initial-final).
  • Abstracts: Author(s).Title, followed by (Abstr). Journal year; volume (Supplement and number if necessary):page(s) or, in case of abstracts not published in journals: Title of the publication. City where published: publisher, year:page(s).

Tables. Up to 5 tables are allowed in original manuscripts (up to 2 tables in short communications, history note or case reports), each presented on a separate page together with its title, notes  and sequence number. Tables should contain all information required to be understood by the reader. Vertical lines should not be used for separating data within the table. Type each table double spaced on a separate page. Do not submit tables as photographs. Number tables consecutively in the order of their first citation in the text and supply a brief title for each. Give each column a short or abbreviated heading. Place explanatory matter in footnotes, not in the heading. Explain in footnotes all non-standard abbreviations used in each table. For footnotes use the following symbols, in this sequence: *, +, §, ||, ¶, **, ++, etc. The editor, on accepting a manuscript, may recommend that additional tables containing important supporting data too extensive to publish be deposited with an archival service, such as the site of the journal (www.demneuropsy.com.br), or be made available by the authors. In this case, an appropriate statement will be added to the text. Submit all tables for consideration together with the manuscript.

Illustrations. Up to 3 figures, graphs or photos are allowed, with their title and notes on separate pages (up to 2 illustrations in short communications, history note or case reports). 

Note. Before sending the manuscript to demneuropsy@uol.com.br, please go through the Author's checklist and complete the Authorship, non-financial, and financial disclosure forms available online from the journal's homepage (www.demneuropsy.com.br).

 

Send of the manuscripts

Submissions must be made online:

https://mc04.manuscriptcentral.com/dn-scielo. Submissions must be accompanied by a cover letter, declaration of Authorship Responsibility, Financial Disclosure and Copyright Transfer/Publishing Agreement. Studies involving humans should be accompanied by a copy of the Ethics Committee authorization from the institution involved. Clinical trial studies will be accepted for publication, pending the presentation of Clinical Trial Registers.

    1. All submitted manuscripts are reviewed initially by an editor. Manuscripts with insufficient priority for publication are rejected promptly.
    2. Initial screening will be performed by a junior editor to verify the formal eligibility of the manuscript according to the editorial norms of Dementia top Neuropsychologia.
    3. Manuscripts are sent for peer-review (see below).
    4. The authors are informed of the probable date of publication following the final decision of the Editor-in-Chief.

The authors may be asked for additional information regarding previous presentations at Scientific Meetings. This information can be supplied in the cover letter sent at the time of manuscript submission.

Note. Before submitting your manuscript, please go through the Author's checklist and complete the Authorship, non-financial, and financial disclosure forms in annex: Authorship Disclosure.

Peer review

    1. After approval of formal aspects, the manuscript is submitted to peer-review and to ad-hoc consultants, as well as international and national specialists. Each manuscript is evaluated by at least two reviewers. Peer reviewers’ identities are kept confidential, and authors' identities are also not disclosed to reviewers.

    2. The referees' comments and suggestions will be sent to the authors of the manuscript within 60 days for reworking of the paper. 

    3. The reformulated version is accepted as a re-submission and re-sent to the referees for further review. 

    4. In the case of referee approval, the manuscript is revised by both the editor and associate editors and proceeds to the publishing step.

    5. In the case of pending issues, the manuscript is again returned to the authors with indications for revision.

    6. The entire process is overseen by the Editor-in-Chief who determines the number of appropriate re-submissions, with a focus on the quality of the work being published at all times.

There are no fees for submission and review articles

 

[Home] [About the journal] [Editorial board] [Subscriptions]


Creative Commons License All the content of the journal, except where otherwise noted, is licensed under a Creative Commons License

Associação de Neurologia Cognitiva e do Comportamento
Rua Itapeva, 538/132 3º andar
01332-000
São Paulo-Brasil
Tel.: (11)3288-8684, 3288-9923


demneuropsy@uol.com.br